巨子 ICON - 財經股票資訊及專家分析
快訊
資訊
    虛擬市場
    搜尋 股票/指數/編號

    快訊

    資訊

    Synaptogenix

    SNPX
    7.290
    0.210
    2.97%
    最少15分鐘延遲,股票資訊由第三方資訊供應商提供
    ・Synaptogenix - 延遲價格・最後更新於 04/10 12:00
    最高位
    7.300
    最低位
    7.100
    開市價
    --
    前收市價
    7.080
    成交量(千)
    2.20
    成交額(百萬)
    0.16
    買入
    --
    賣出
    --
    每手股數
    --
    市值(百萬)
    49.87
    市盈率
    --
    息率
    --
    差價
    --
    52週高低
    14.500 - 3.790
    所有資料不保證絕對正確、完整、或實時,僅作為參考使用。投資涉及風險,過往業績並不代表將來表現,作任何投資決定或交易前,閣下應諮詢獨立專業意見。所有內容均不構成投資建議。

    企業資料

    公司名稱
    Synaptogenix
    證券代碼
    SNPX.US
    所屬板塊
    Biotechnology
    公司業務
    Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
    發行量
    3508129
    公司總部
    1185 Avenue of the Americas, 3rd Floor
    公司網址
    https://www.synaptogen.com
    公司電話
    +1 973 242-0005
    暫無內容

    關於

    Synaptogenix(SNPX.US)所屬的行業板塊為Biotechnology。
    Synaptogenix Inc is a biopharmaceutical company with product candidates in pre-clinical and clinical development. It is principally focused on developing a product platform based upon a drug candidate called bryostatin for the treatment of Alzheimer's disease, which is in the clinical testing stage. It is also evaluating bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis, and Niemann-Pick Type C disease, which have undergone pre-clinical testing.
    詳細公司背景可參考: https://www.synaptogen.com